Maxim Group downgraded Biostage (NASDAQ: BSTG) from Buy to Hold, citing a financing overhang.Analyst Jason Kolbert highlighted:Biostage reported 3Q16, losing ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE